IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q4 2022 Holdings

Filed 2023-02-14 | 11 holdings | $237.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Amryt Pharma PLCSponsored ADS03217L106$64.7M8,857,26827.2%
Biora Inc.Note 7.250% 12/074319FAB3$56.3M$103,500,00023.6%
Omeros CorpNOTE 5.250% 2/1682143AG7$31.7M$58,131,00013.3%
Omeros CorpNOTE 6.250%11/1682143AE2$20.2M$21,005,0008.5%
RVL Pharmaceuticals PLCSHSG6S41R101$16.4M14,600,4446.9%
Caremax IncCOM CL A14171W103$16.3M4,467,2196.9%
Paratek Pharmaceuticals Inc.NOTE 4.750% 5/0699374AB0$8.2M$9,000,0003.5%
BridgeBio Pharma Inc.NOTE 2.250% 2/010806XAD4$7.8M$20,000,0003.3%
Puma Biotechnology Inc(PBYI)COM74587V107$7.6M1,792,1143.2%
Biora Inc.COM74319F107$5.6M42,362,0972.3%
Societal Cdmo Inc.Com75629F109$3.3M2,202,4201.4%